Clinical Trials Browser

Phase 1 × Prostatic Neoplasms × nintedanib × Clear all

NCT02182219 2025-01-22

Oral Treatment With BIBF 1120 Together With Docetaxel and Prednisone in Patients With Hormone Refractory Prostate Cancer

Phase 1 Completed

Prostatic Neoplasms